Cardiac amyloidosis is a rare condition defined by the abnormal production of proteins that bind together to form amyloid proteins. These amyloids can gather in different organs throughout the ...

The stock market responded positively to the company's announcement, with its share price leaping more than 28% following the ...

Ultromics Ltd. received clearance from the U.S. FDA for Echogo Amyloidosis, its artificial intelligence-enhanced software ...

REPLY: Thank you for your eagle-eyed attention to detail and for bringing the inconsistency to our attention regarding the SPECT reconstruction display between 2 articles published in the June 2023 ...

Cardiac amyloidosis is a condition that occurs when abnormal proteins called "amyloid" build up in your heart. These proteins can develop and grow in the heart tissue, increasing your risk for ...

When it occurs in the heart, it's called cardiac amyloidosis. Dr. Martha Grogan, a Mayo Clinic cardiologist and director of ...

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Cardiac amyloidosis has a wide spectrum of clinical manifestations but the ...

Several case reports and retrospective cohort studies have described a marginal benefit with the use of internal cardioverter defibrillators in patients with cardiac amyloidosis. Detection of ...

Training product provides healthcare practitioners, medical schools, and health systems with a simple, effective, and accessible program for mastering cardiac ultrasounds. BORDEAUX, France ...